Status | Study |
Withdrawn |
Study Name: Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka Condition: Human Papillomavirus Infection Date: 2012-03-08 Interventions: Other: Cervarix data collection |
Terminated |
Study Name: GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077) Condition: Papillomavirus Infections Date: 2011-05-16 |
Completed |
Study Name: A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008). Condition: Papillomavirus Infections Date: 2010-12-03 Interventions: Biological: V503 V503 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6 |
Completed |
Study Name: GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046) Condition: Papillomavirus Infections Date: 2010-11-19 Interventions: Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombin |
Completed |
Study Name: Self-collected Swabs for HPV Testing in 18-24 Year Old Women Condition: Papillomavirus Infections Date: 2010-04-07 |
Completed |
Study Name: A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007) Condition: Papillomavirus Infections Date: 2010-02-19 Interventions: Biological: V503 Vaccine V503 |
Completed |
Study Name: Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men Condition: Human Papillomavirus Infection Date: 2009-06-30 |
Completed |
Study Name: The Human Papillomavirus (HPV) Transmission Pilot Study Condition: Human Papillomavirus Infection Date: 2009-01-13 |
Completed |
Study Name: Human Papillomavirus 6/11 in the Lower Airway of Neonates Condition: Papillomavirus Infections Date: 2007-10-24 |
Completed |
Study Name: Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities Condition: Papillomavirus Infections Date: 2007-07-12 Interventions: Biological: human papillomavirus vaccine L1, type 6,11,16,18 Subjects are those getting gradasil vaccina |